These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
294 related items for PubMed ID: 3110292
1. Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells. Fletcher WH, Shiu WW, Ishida TA, Haviland DL, Ware CF. J Immunol; 1987 Aug 01; 139(3):956-62. PubMed ID: 3110292 [Abstract] [Full Text] [Related]
2. Target cell DNA fragmentation is mediated by lymphotoxin and tumor necrosis factor. Schmid DS, Hornung R, McGrath KM, Paul N, Ruddle NH. Lymphokine Res; 1987 Aug 01; 6(3):195-202. PubMed ID: 3498099 [Abstract] [Full Text] [Related]
3. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. Browning J, Ribolini A. J Immunol; 1989 Sep 15; 143(6):1859-67. PubMed ID: 2550545 [Abstract] [Full Text] [Related]
4. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. Ortaldo JR, Ransom JR, Sayers TJ, Herberman RB. J Immunol; 1986 Nov 01; 137(9):2857-63. PubMed ID: 3093586 [Abstract] [Full Text] [Related]
6. Intercellular communication is reduced by TPA and Ki-ras p21 in quiescent, but not proliferating, NRK cells. Paulson AF, Johnson RG, Atkinson MM. Exp Cell Res; 1994 Jul 01; 213(1):64-70. PubMed ID: 8020607 [Abstract] [Full Text] [Related]
7. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice. Granger GA, Masunaka I, Averbook B, Kobayashi M, Fitzgerald M, Yamamoto R. J Biol Response Mod; 1988 Oct 01; 7(5):488-97. PubMed ID: 3263472 [Abstract] [Full Text] [Related]
9. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. Pober JS, Lapierre LA, Stolpen AH, Brock TA, Springer TA, Fiers W, Bevilacqua MP, Mendrick DL, Gimbrone MA. J Immunol; 1987 May 15; 138(10):3319-24. PubMed ID: 3494766 [Abstract] [Full Text] [Related]
10. PI3K/Akt signaling is involved in the disruption of gap junctional communication caused by v-Src and TNF-α. Ito S, Hyodo T, Hasegawa H, Yuan H, Hamaguchi M, Senga T. Biochem Biophys Res Commun; 2010 Sep 17; 400(2):230-5. PubMed ID: 20727856 [Abstract] [Full Text] [Related]
11. The human LT system. XII. Purification and functional studies of LT and "TNF-like" LT forms from a continuous human T cell line. Kobayashi M, Plunkett JM, Masunaka IK, Yamamoto RS, Granger GA. J Immunol; 1986 Sep 15; 137(6):1885-92. PubMed ID: 2427583 [Abstract] [Full Text] [Related]
12. Partial characterization of the mitogenic action of pp60v-src, the oncogenic protein product of the src gene of avian sarcoma virus. Durkin JP, Whitfield JF. J Cell Physiol; 1984 Aug 15; 120(2):135-45. PubMed ID: 6086674 [Abstract] [Full Text] [Related]
13. Phosphorylation of connexin43 in cells containing mutant src oncogenes. Crow DS, Kurata WE, Lau AF. Oncogene; 1992 May 15; 7(5):999-1003. PubMed ID: 1315016 [Abstract] [Full Text] [Related]
14. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. Browning JL, Dougas I, Ngam-ek A, Bourdon PR, Ehrenfels BN, Miatkowski K, Zafari M, Yampaglia AM, Lawton P, Meier W. J Immunol; 1995 Jan 01; 154(1):33-46. PubMed ID: 7995952 [Abstract] [Full Text] [Related]
15. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer. Cappuccini F, Yamamoto RS, DiSaia PJ, Grosen EA, Gatanaga M, Lucci JA, Ininns EK, Gatanaga T, Granger GA. Lymphokine Cytokine Res; 1991 Jun 01; 10(3):225-9. PubMed ID: 1653048 [Abstract] [Full Text] [Related]
16. Growth inhibition of oncogene-transformed rat fibroblasts by cocultured normal cells: relevance of metabolic cooperation mediated by gap junctions. Martin W, Zempel G, Hülser D, Willecke K. Cancer Res; 1991 Oct 01; 51(19):5348-51. PubMed ID: 1913656 [Abstract] [Full Text] [Related]
17. Polyphosphoinositide metabolism is rapidly stimulated by activation of a temperature-sensitive mutant of Rous sarcoma virus in rat fibroblasts. Chiarugi V, Porciatti F, Pasquali F, Magnelli L, Giannelli S, Ruggiero M. Oncogene; 1987 Oct 01; 2(1):37-40. PubMed ID: 2830581 [Abstract] [Full Text] [Related]
18. Inhibition of gap junction-mediated intercellular communication by TNF-alpha in cultured human corneal fibroblasts. Hao JL, Suzuki K, Lu Y, Hirano S, Fukuda K, Kumagai N, Kimura K, Nishida T. Invest Ophthalmol Vis Sci; 2005 Apr 01; 46(4):1195-200. PubMed ID: 15790879 [Abstract] [Full Text] [Related]
19. [Effects of tumor promoting herb Wikstroemia chamaedaphne extract on V79 cells and WB liver cells: I. Correlation between cellular growth and gap junctional intercellular communication]. Lin ZX, Lü GZ, Jiang SW, Zhou LX, Han YL. Shi Yan Sheng Wu Xue Bao; 1991 Dec 01; 24(4):307-15. PubMed ID: 1796715 [Abstract] [Full Text] [Related]
20. Effects of v-src oncogene activation on radiation sensitivity in drug-sensitive and in multidrug-resistant rat fibroblasts. Shimm DS, Miller PR, Lin T, Moulinier PP, Hill AB. Radiat Res; 1992 Feb 01; 129(2):149-56. PubMed ID: 1734444 [Abstract] [Full Text] [Related] Page: [Next] [New Search]